nortriptyline has been researched along with Peripheral Nervous System Diseases in 5 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
| Excerpt | Relevance | Reference |
|---|---|---|
| "No significant differences in paresthesia were observed in the first treatment period between nortriptyline and placebo (means of 49 and 55 respectively on a 0-100 point scale, P=0." | 2.70 | Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. ( Hammack, JE; Johnson, JA; Loprinzi, CL; Michalak, JC; Novotny, PJ; Rowland, KM; Sloan, JA; Soori, GS; Stella, PJ; Tirona, MT, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, WQ | 1 |
| Kanungo, A | 1 |
| Toth, C | 1 |
| Yi, BA | 1 |
| Nirenberg, MJ | 1 |
| Goldstein, SM | 1 |
| Berger, TG | 1 |
| Benbouzid, M | 1 |
| Choucair-Jaafar, N | 1 |
| Yalcin, I | 1 |
| Waltisperger, E | 1 |
| Muller, A | 1 |
| Freund-Mercier, MJ | 1 |
| Barrot, M | 1 |
| Benazzi, F | 1 |
| Ciucci, G | 1 |
| Hammack, JE | 1 |
| Michalak, JC | 1 |
| Loprinzi, CL | 1 |
| Sloan, JA | 1 |
| Novotny, PJ | 1 |
| Soori, GS | 1 |
| Tirona, MT | 1 |
| Rowland, KM | 1 |
| Stella, PJ | 1 |
| Johnson, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Kinetics of Endocannabinoids in Patients With Chemotherapy Induced Peripheral Neuropathy by Using a Portable Metered-Dose Cannabis Inhaler[NCT04376437] | 40 participants (Anticipated) | Interventional | 2022-03-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for nortriptyline and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Equivalency of tricyclic antidepressants in open-label neuropathic pain study.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Drug Therapy, Combination; Female; Humans; Male; Mi | 2014 |
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.
Topics: Antidepressive Agents, Tricyclic; Cisplatin; Cross-Over Studies; Dose-Response Relationship, Drug; D | 2002 |
3 other studies available for nortriptyline and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Chronic neuropathic pain associated with imiquimod: report of 2 cases.
Topics: Aminoquinolines; Antiviral Agents; Chronic Disease; Female; Humans; Imiquimod; Male; Middle Aged; No | 2005 |
Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.
Topics: Amines; Amitriptyline; Animals; Anticonvulsants; Antidepressive Agents, Tricyclic; Brain; Chronic Di | 2008 |
Neuropathy associated with tricyclic antidepressants.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Desipramine; Female; Humans; Middle Aged; Nortriptylin | 1997 |